Bonnutti Technologies has a track record of identifying problems and has more than 500 patents—tell me about your latest breakthrough with Releave which is being used by 700 patients already.
What is the problem you are solving?
How many people suffer from cluster headaches and neuro disorders?
What is the science behind Releave? How does Releave work? Is it an implant and a device?
There is a lot of talk about chip implants…not approved by the FDA. You are approved and have patients, how hard was the process?
How are you funded and who is the team behind the project?
How can potential patients and medical professionals learn more about Realeve?
Dr. Peter Bonutti, M.D. is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.
Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.
In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.